ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Merck

MERCK & COMPANY

Merck & Company

Patient and Reimbursement Assistance

https://www.merckaccessprogram.com/hcp/

Phone Number

855.257.3932

Merck offers the Merck Access Program to patients prescribed a Merck oncology product. The Merck Access Program may be able to help answer questions about access and support.

For more information, search the prescribed Merck product in this Guide, go online, or call 855.257.3932, Monday through Friday, 8:00 AM to 8:00 PM EST.

Oncology-related products: Emend® (fosaprepitant dimeglumine) for injection, Emend® (aprepitant) capsules, Gardasil®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) suspension for intramuscular injection, Intron® A (interferon alfa-2b, recombinant) for injection, Keytruda® (pembrolizumab) injection, Ontruzant® (trastuzumab-dttb) for injection, Welireg™ (belzutifan) tablets, Zolinza® (vorinostat) capsules

Reimbursement Assistance

Merck Access Program

The Merck Access Program may be able to help answer questions about access and support, including:

  • Benefits investigations and the prior authorization and appeal process.
  • Insurance coverage for patients.

Benefit Investigations

The Merck Access Program can contact insurers to request coverage and benefits information. Visit Merck Access Program or the specific Merck product site for additional resources.

Prior Authorizations

If a prior authorization is required, or for assistance in understanding if a prior authorization is required, the Merck Access Program may be able to help. The prior authorization checklist and sample letter can help healthcare professionals understand the documents and information that may be helpful when seeking a prior authorization. As always, healthcare providers should check for payer-specific requirements.

Appeals

The program may be able to help healthcare professionals understand the information needed for an appeal submission. The appeal checklist and sample appeal letter can help you to understand the documents and information that may be helpful when filing an appeal. Check for payer-specific requirements.

To find all available Merck resources, visit the prescribed medication's website.

For any questions, call 855.257.3932, Monday through Friday, 8:00 AM to 8:00 PM EST.

Independent Charitable Foundations/Organizations

Merck Access Program Referrals

If patients are ineligible for the Merck Co-Pay Assistance Program, they may be able to get help from an independent co-pay assistance foundation. A Merck Access Program representative can provide information about independent foundations that be able to provide financial support to patients who do not qualify for the Merck Co-Pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.

For further assistance, call 855.257.3932, Monday through Friday, 8:00 AM to 8:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Merck Co-Pay Assistance Program

The Merck Co-pay Assistance Program offers assistance to eligible, privately insured patients who need help affording their out-of-pockets costs. Once enrolled, patients prescribed Keytruda will pay the first $25 of their co-pay per infusion, subject to a maximum co-pay assistance program benefit of $25,000 per patient, per calendar year.

For patients prescribed Welireg, patients are responsible for the first $5 of out-of-pocket cost on each prescription, subject to a maximum program savings of $8,700 per patient. Coupon is valid for up to a 90-day supply per prescription fill. Coupon may be redeemed only once every 21 days.

Co-pay assistance may be available for patients who:

  • Are a resident of the United States (including Puerto Rico)
  • Have private health insurance that provides coverage for the Merck medicine under a medical benefit program
  • Have been prescribed an eligible Merck medicine for an FDA-approved indication
  • Meet all other terms and conditions of the program.

The Merck Co-pay Assistance Program is not valid for patients covered under a government program, as that term is defined in the program's terms and conditions. The program is not valid for uninsured patients.

Enroll online for Keytruda or Welireg or visit the Merck Access Program website, select the prescribed medication, and fax the completed enrollment form to the number listed.

For further assistance, call 855.257.3932, Monday through Friday, 8:00 AM to 8:00 PM EST.

Patient Assistance Program

Merck Patient Assistance Program

The Merck Patient Assistance Program provides certain medicines and adult vaccines for free to people who do not have prescription drug coverage and who, without assistance, could not afford their Merck medicines and vaccines.

Individuals who don’t meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial and medical hardship, and their income meets the program criteria. A single application may provide for up to one year of medicine free of charge to eligible individuals and an individual may reapply as many times as needed

Patients may qualify for patient assistance if they meet all three of the following conditions:

  • Patients must be a United States resident and have a prescription for a Merck product from a healthcare provider licensed in the U.S.
  • Patient does has insurance or other coverage for their prescription medication.
  • Patient cannot afford to pay for their medication.

To apply, patients and providers must complete the Enrollment Form for the specific Merck medication. Visit merckhelps.com and search for the specific medication, download and complete the medication’s enrollment form, and mail all completed forms to the address listed.

For assistance, call 855.257.3932.

Merck Vaccine Patient Assistance Program

The Merck Patient Assistance Program provides certain medicines and adult vaccines for free to people who do not have prescription drug coverage and who, without assistance, could not afford their Merck medicines and vaccines.

Individuals who don’t meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial and medical hardship, and their income meets the program criteria. A single application may provide for up to one year of medicine free of charge to eligible individuals and an individual may reapply as many times as needed

Patients may qualify for patient assistance if they meet all three of the following conditions:

  • Patients must reside in the United States resident and are 19 to 45 years of age.
  • Patient has no health insurance coverage.
  • Patient has an annual household income that meets program eligibility.

Patients do not have to be a U.S. citizen. Residents of the U.S., including U.S. territories, are also eligible.

To apply, fax the completed enrollment form to 800.528.2551.

For assistance, call 800.293.3881, Monday through Friday, 8:00 AM to 8:00 PM EST.